Currently, NLS Pharmaceutics Ltd’s (NLSP) stock is trading at $2.32, marking a gain of 16.01% from last night’s close. At this price, the stock is -90.47% below its 52-week high of $24.34 and 34.12% above its 52-week low of $1.73. Based on the past 30-day period, the stock price is -41.02% below the high and +26.83% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, NLSP’s SMA-200 is $6.02.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How does NLS Pharmaceutics Ltd (NLSP) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
NLS Pharmaceutics Ltd (NASDAQ: NLSP) Ownership Details
I will give a breakdown of the key shareholders in NLS Pharmaceutics Ltd (NLSP). Recent figures show that the company’s insiders hold 40.85% of shares. A total of 5 institutional investors hold shares in the company, making 19.40% of its stock and 32.80% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is BVF Inc. holding total of 143.68 shares that make 3.77% of the company’s total number of shares and are currently priced at 0.35 million.
The securities firm UBS Group AG holds 4.72 shares of NLSP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.12%, and the holding percentage of shares is valued at 11561.0.
An overview of NLS Pharmaceutics Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests NLS Pharmaceutics Ltd (NLSP) traded 481,240 shares per day, with a moving average of $2.56 and price change of -1.10. With the moving average of $3.50 and a price change of -2.90, about 449,206 shares changed hands on average over the past 50 days. Finally, NLSP’s 100-day average volume is 234,624 shares, alongside a moving average of $4.88 and a price change of -7.49.
